Prognostic value of the lymphocyte-to-monocyte ratio in predicting axillary lymph node metastasis in breast cancer
Annals of Clinical and Analytical Medicine · 01.05.2026 · 17 (5) · 468-471
DOI: 10.4328/acam.22872 ↗Kurz gefasst
Fachartikel in der Zeitschrift Annals of Clinical and Analytical Medicine, erschienen am 01.05.2026. Verfasst von Bahadır Öndeş und 1 weiteren Autor:innen. Die Arbeit nennt 20 Literaturangaben.
Abstract (Originalsprache)
Aim
Axillary lymph node metastasis is one of the most important parameters in determining the prognosis and therapeutic approach in patients with malignant breast disease. In recent years, systemic inflammatory markers have been shown to be associated with tumor biology and metastatic potential. The objective of this study was to investigate the relationship between the lymphocyte-to-monocyte ratio and axillary lymph node metastasis.
Methods
A total of 140 patients who underwent surgery for malignant breast disease between 2021 and 2024 were retrospectively evaluated. Demographic data, type of surgical procedure, number of excised lymph nodes, presence of metastatic lymph nodes, and hematological parameters were reviewed. The lymphocyte-to-monocyte ratio was calculated by dividing the absolute lymphocyte count by the absolute monocyte count obtained from the preoperative complete blood count. Patients were categorized into two groups according to the presence or absence of axillary lymph node metastasis, and the lymphocyte-to-monocyte ratio values were compared between the groups.
Results
Axillary lymph node metastasis was detected in 62 patients (44.3%). The mean lymphocyte-to-monocyte ratio was 3.99 in the metastasis-positive group and 5.01 in the metastasis-negative group. Although the mean lymphocyte-to-monocyte ratio was lower in patients with nodal metastasis, this difference did not reach statistical significance according to the Mann–Whitney U test.
Conclusion
In breast cancer patients, those with axillary lymph node metastasis tended to have lower lymphocyte-to-monocyte ratio values. However, this difference was not statistically significant. Larger cohorts and prospective studies are warranted to clarify the potential role of the lymphocyte-to-monocyte ratio as a predictor of axillary nodal involvement.
Zitieren
APA
Öndeş, B., & Gökdere, O. G. (2026). Prognostic value of the lymphocyte-to-monocyte ratio in predicting axillary lymph node metastasis in breast cancer. Annals of Clinical and Analytical Medicine, 17(5), 468-471. https://doi.org/10.4328/acam.22872
Vancouver
Öndeş B, Gökdere OG. Prognostic value of the lymphocyte-to-monocyte ratio in predicting axillary lymph node metastasis in breast cancer. Annals of Clinical and Analytical Medicine. 2026;17(5):468-471. doi:10.4328/acam.22872
BibTeX
@article{nde2026,
author = {Öndeş, Bahadır and Gökdere, Osman Gökhan},
title = {Prognostic value of the lymphocyte-to-monocyte ratio in predicting axillary lymph node metastasis in breast cancer},
journal = {Annals of Clinical and Analytical Medicine},
year = {2026},
volume = {17},
number = {5},
pages = {468--471},
doi = {10.4328/acam.22872}
}
EUVIMED